General Management
-
- February 2, 2023
- Article
How to Build a Life: The Hidden Link Between Workaholism and Mental Health
By: Arthur C. Brooks- February 2, 2023
- Article
How to Build a Life: The Hidden Link Between Workaholism and Mental Health
By: Arthur C. Brooks -
- January 2023
- Case
Natura: Weathering the Pandemic at Brazil's Cosmetic Giant
By: Brian Trelstad, Pedro Levindo and Carla LarangeiraBrazil's Natura, a multi-brand cosmetics group, has taken several measures to safeguard the livelihoods of its thousands of employees and millions of sales representatives during the COVID-19 health and economic crisis. The company has also made strides in its efforts to increase digital sales. Now the purpose-driven group must decide whether to vocalize its opposition to private companies buying COVID-19 vaccines to inoculate their employees before priority groups in Brazil's public health system.
- January 2023
- Case
Natura: Weathering the Pandemic at Brazil's Cosmetic Giant
By: Brian Trelstad, Pedro Levindo and Carla LarangeiraBrazil's Natura, a multi-brand cosmetics group, has taken several measures to safeguard the livelihoods of its thousands of employees and millions of sales representatives during the COVID-19 health and economic crisis. The company has also made strides in its efforts to increase digital sales. Now the purpose-driven group must decide whether to...
-
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian WalkerHow can a successful executive assess her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to find a therapeutic window for Cleave Therapeutics oncology drug was on track but faced an uncertain future. Overseeing the human trials of a refined second-generation drug candidate, Amy had led the company back from the “valley of death” after Cleave’s initial offering resulted in off-target toxicity. Still, after completing multiple dose escalation cohorts, Cleave’s scientists told Amy that they could not draw any definitive conclusions about the benefits of the drug. Amy and her team knew the importance of speed and capital in the high-risk business of oncology drug development where success often takes more resources and time than expected and competitors lurk. Nearing the close of a five-year investment window, should the thinly staffed Cleave 2.0 continue to recruit patients and clear dosing cohorts at a rapid rate, or should Amy prioritize funding and partnership discussions?
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian WalkerHow can a successful executive assess her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to find a therapeutic window for Cleave Therapeutics oncology drug was on track but faced an uncertain future. Overseeing the human trials of a refined second-generation drug candidate, Amy had led the...
About the Unit
The General Management Unit is concerned with the leadership and management of the enterprise as a whole. This concern encompasses:
- the personal values and qualities of effective general managers and enterprise leaders;
- the philosophies, values, and strategies that inform successful enterprises; and
- the relation of enterprise to the broader community and other external constituencies.
The Unit's work is conceived and carried out principally in four interest groups, each of which has its own leadership, research agenda, and teaching programs:
- Management Policy and Process
- Management Information Systems
- Society and Enterprise
- Leadership, Values, and Corporate Responsibility
Recent Publications
How to Build a Life: The Hidden Link Between Workaholism and Mental Health
- February 2, 2023 |
- Article |
- The Atlantic
Natura: Weathering the Pandemic at Brazil's Cosmetic Giant
- January 2023 |
- Case |
- Faculty Research
LCA Action Planning: Responsibility and Accountability
- January 2023 |
- Module Note |
- Faculty Research
Ethical Analysis: Honesty and Self-Interest
- January 2023 |
- Technical Note |
- Faculty Research
Apple: Privacy vs. Safety (B)
- January 2023 |
- Supplement |
- Faculty Research
How to Build a Life: Nothing Drains You Like Mixed Emotions
- January 19, 2023 |
- Article |
- The Atlantic
Identify the Health Care Venture
- January 2023 |
- Teaching Note |
- Faculty Research
Harvard Business Publishing
Seminars & Conferences
There are no upcoming events.